Seoul, South Korea

You H Hong


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: You H Hong: Innovator in Thiazine Chemistry

Introduction

You H Hong is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of innovative processes for synthesizing complex chemical compounds. His work has implications for the pharmaceutical industry, especially in the creation of effective anti-inflammatory agents.

Latest Patents

You H Hong holds a patent for a process titled "Process for the preparation of 3,4-dihydro-2-substituted-4(or 3)-oxo-2H-1,2-thiazine-3(or 4)-carboxylic acid 1,1-dioxide magnesium chelate derivatives and its acids." This process involves reacting 3,4-dihydro-2-substituted-4(or 3)-oxo-2H-1,2-thiazine 1,1-dioxides with alkylmagnesium carbonate, followed by hydrolysis. The resulting compounds serve as intermediates for the preparation of N-substituted-2-substituted-2H-1,2-thiazine-3(or 4)-carboxamide-1,1-dioxide derivatives, which are recognized as effective anti-inflammatory agents. He has 1 patent to his name.

Career Highlights

You H Hong is associated with Yuhan Corporation Co., Ltd., a leading pharmaceutical company in South Korea. His role at Yuhan Corporation has allowed him to focus on research and development, contributing to advancements in medicinal chemistry. His innovative approaches have positioned him as a key figure in the field.

Collaborations

You H Hong has worked alongside his coworker, Jung J Suh, to further enhance the research and development efforts at Yuhan Corporation. Their collaboration has led to significant advancements in the synthesis of thiazine derivatives.

Conclusion

You H Hong's contributions to the field of chemistry, particularly through his patented processes, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…